Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules

International Journal of Pediatric Otorhinolaryngology

Volumn 77, Issue 10, 2013, Pages 1697-1700

  Buryk, Melissa A ^a   Monaco, Sara E ^b   Witchel, Selma F ^a   Mehta, Deepak K ^a,b   Gurtunca, Nursen ^a   Nikiforov, Yuri E ^b   Simons, Jeffrey P ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Fine needle aspiration; Molecular mutation; Pediatric; Thyroid cancer; Thyroid nodule; Thyroidectomy

Indexed keywords

CALCIUM;

ADOLESCENT; ARTICLE; BRAF V600E GENE; CHILD; CLINICAL ARTICLE; CYTOLOGY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENE; GENE MUTATION; HRAS61 GENE; HUMAN; HYPOCALCEMIA; MALE; MEDICAL DECISION MAKING; MUTATIONAL ANALYSIS; PAX8 GENE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PPARG GENE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PTC1 GENE; RET GENE; RETROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID FUNCTION TEST; THYROID NODULE; THYROIDECTOMY; ULTRASOUND;

FINE-NEEDLE ASPIRATION; MOLECULAR MUTATION; PEDIATRIC; THYROID CANCER; THYROID NODULE; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; BIOPSY, FINE-NEEDLE; CHILD; CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENETIC TESTING; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PAIRED BOX TRANSCRIPTION FACTORS; PREOPERATIVE CARE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENE PROTEINS P21(RAS); RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84884281780     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2013.07.029     Document Type: Article

References (16)

1. Corrias A., Mussa A., Baronio F., Arrigo T., Salerno M., Segni M., et al. Diagnostic features of thyroid nodules in pediatrics. Arch. Pediatr. Adolesc. Med. 2010, 164:714-719.
2. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr. Relat. Cancer 2006, 13:427-453.
3. Monaco S., Pantanowitz L., Khalbuss W., Benkovich V., Ozolek J., Nikiforova M., et al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. Cancer Cytopathol. 2012, 120:342-350.
4. Cibas E.S., Ali S.Z. The Bethesda System for Reporting Thyroid Cytopathology. Am. J. Clin. Pathol. 2009, 132:658-665.
5. Nikiforov Y.E., Sterward D.L., Robinson-Smith T.M., Haugen B.R., Klopper J.P., Zhu Z., et al. Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. J. Clin. Endocrinol. Metab. 2009, 94:2092-2098.
6. Nikiforov Y.E., Ohori N.P., Hodak S.P., Carty S.E., LeBeau S.O., Ferris R.L., et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indetminate thyroid nodules: a prospective analysis of 1056 FNA samples. J. Clin. Endocrinol. Metab. 2011, 96:3390-3397.
7. Nikiforov Y.E., Nikiforova M.N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 2011, 7:569-580.
8. Elisei R., Ugolini C., Viola D., Lupi C., Biagini A., Giannini R., et al. BRAF (V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J. Clin. Endocrinol. Metab. 2008, 93:3943-3949.
9. Xing M., Clark D., Guan H., Ji M., Dackiw A., Carson K.A., et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J. Clin. Oncol. 2009, 27:2977-2982.
10. Howell G.M., Nikiforova M.N., Carty S.E., Armstrong M.J., Hodak S.P., Stang M.T., et al. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann. Surg. Oncol. 2013, 20:47-52.
11. Ohori N.P., Singhal R., Nikiforova M.N., Yip L., Schoedel K.E., Coyne C., et al. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma. Cancer Cytopathol. 2012, Aug 7. [Epub ahead of print].
12. O'Neill C., Bullock M., Chou A., Sidhu S.B., Delbridge L.W., Robinson B.G., et al. BRAF V600E mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery 2010, 148:1139-1146.
13. Bongarzone I., Fugzzola L., Vigneri P., Mariani L., Mondellini P., Pacini F., et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1996, 81:2006-2009.
14. Sounacer A., Wicker R., Calliou B., Callieux A.F., Sarasin A., Schlumberger M., et al. High prevalence of activating ret protooncogene rearrangements, in thyroid tumors from patients who had received external radition. Oncogene 1997, 15:1263-1273.
15. Gupta N., Dasyam A., Carty S., Nikiforova M.N., Ohori N.P., Armstrong M., et al. RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular pattern cancers. J. Clin. Endocrinol. Metab. 2013, 98. [Epub ahead of print].
16. Yip L., Farris C., Kabaker A., Hodak S.P., Nikiforova M.N., McCoy K.L., et al. Cost of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J. Clin. Endocrinol. Metab. 2012, 97:1905-1912.